Phase 3 Ischemic Stroke, Acute Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Phase 2Phase 3
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Central Nervous System DiseasesCerebrovascular DisordersIschemic Stroke, Acute+1 more
University of Melbourne462 enrolled13 locationsNCT05892510
Recruiting
Phase 3
Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
Ischemic Stroke, Acute
Hospital Moinhos de Vento466 enrolled15 locationsNCT05199662
Recruiting
Phase 3
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )
Ischemic Stroke, Acute
Beijing Tiantan Hospital600 enrolled1 locationNCT06522282
Recruiting
Phase 3
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
TIAIschemic Stroke, Acute
Beijing Tiantan Hospital4,674 enrolled5 locationsNCT06319846